Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients The Meropenem Study Group of Leuven, London and Nijmegen The Meropenem Study Group of Leuven, London and Nijmegen Search for other works by this author on: Oxford Academic PubMed Google Scholar *The members of the Study Group are as follows: M. A. Boogaerts, H. Demuynck, N. Mestdagh and L. Verbist, University Hospital Gasthuisberg, Leuven, Belgium; A. H. Goldstone, H. C. Kelsey and S. Machin, University College Hospital, London, UK; B. E. De Pauw, J. P. Donnelly and J. M. M. Raemaekers, University Hospital St Radboud, Nijmegen, The Netherlands; and G. Atkinson and K. J. Williams, Zeneca Pharmaceuticals, Macclesfield, Cheshire, UK Author Notes Journal of Antimicrobial Chemotherapy, Volume 36, Issue 1, July 1995, Pages 185–200, https://doi.org/10.1093/jac/36.1.185 Published: 01 July 1995 Article history Received: 19 April 1994 Revision received: 08 September 1994 Accepted: 24 February 1995 Published: 01 July 1995